AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 20-E-02-020.01
CMS should educate Part D beneficiaries about access to MAT drugs and naloxone.
The recommendation, in the publisher's words
CMS should educate Part D beneficiaries about access to MAT drugs and naloxone.
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- May 4, 2020
- Report
- Medicare Part D Beneficiaries at Serious Risk of Opioid Misuse or Overdose: A Closer Look (OEI-02-19-00130) · find it at HHS OIG
- Kind of report
- Evaluation
- Agency response
- Concur (as recorded by the publisher)
- Closed
- March 24, 2022 (publisher's date)
- Publisher topics
- Prescription Drug, Substance Abuse Disorder
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Implemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.